Home > Compound List > Product Information
Pipecuronium_Molecular_structure_CAS_68399-58-6)
Click picture or here to close

Pipecuronium

Catalog No. DB01338 Name DrugBank
CAS Number 68399-58-6 Website http://www.ualberta.ca/
M. F. C35H62N4O4++ Telephone (780) 492-3111
M. W. 602.89118 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 1170

SYNONYMS

IUPAC name
4-[(1S,2S,4S,5S,7S,10R,11S,13S,14R,15S)-5,14-bis(acetyloxy)-4-(4,4-dimethylpiperazin-4-ium-1-yl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-13-yl]-1,1-dimethylpiperazin-1-ium
IUPAC Traditional name
4-[(1S,2S,4S,5S,7S,10R,11S,13S,14R,15S)-5,14-bis(acetyloxy)-4-(4,4-dimethylpiperazin-4-ium-1-yl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-13-yl]-1,1-dimethylpiperazin-1-ium
Brand Name
Raplon
Synonyms
Pipecurium
Pipecuronium bromide

DATABASE IDS

PubChem CID 50192
CAS Number 68399-58-6
PubChem SID 46508493

PROPERTIES

DETAILS

Description (English)
Item Information
Drug Groups approved
Description Pipecuronium is a piperazinyl androstane derivative which is a non-depolarizing neuromuscular blocking agent.
Indication Used as a muscle relaxant during anesthesia and surgical procedures.
Pharmacology Pipecuronium is a nondepolarizing neuromuscular blocking agent. Neuromuscular blocking agents produce skeletal muscle paralysis by blocking neural transmission at the myoneural junction. The paralysis is selective initially and usually appears in the following muscles consecutively: levator muscles of eyelids, muscles of mastication, limb muscles, abdominal muscles, muscles of the glottis, and finally, the intercostal muscles and the diaphragm. Neuromuscular blocking agents have no clinically significant effect on consciousness or the pain threshold.
Affected Organisms
Humans and other mammals
Half Life Distribution Normal renal function: 6.22 (range, 1.34 to 10.66) minutes. Renal function impairment: 4.33 (range, 1.69 to 6.17) minutes. Elimination Normal renal function: 1.7 (range, 0.9 to 2.7) hours. The elimination half-life is not altered by hypothermia and bypass. Renal function impairment: 4 (range, 2 to 8.2) hours. [PharmGKB]
External Links
Wikipedia

REFERENCES